Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

BUY
$1.25 - $2.51 $5,692 - $11,430
4,554 Added 3252.86%
4,694 $6,000
Q3 2023

Nov 13, 2023

BUY
$2.15 - $3.59 $212 - $355
99 Added 241.46%
140 $0
Q2 2023

Aug 15, 2023

BUY
$2.52 - $4.0 $7 - $12
3 Added 7.89%
41 $0
Q1 2023

May 12, 2023

BUY
$2.66 - $4.36 $2 - $4
1 Added 2.7%
38 $0
Q4 2022

Feb 13, 2023

BUY
$2.81 - $39.7 $2 - $39
1 Added 2.78%
37 $0
Q3 2022

Nov 14, 2022

BUY
$3.97 - $42.7 $15 - $170
4 Added 12.5%
36 $0
Q2 2022

Aug 12, 2022

BUY
$5.93 - $15.61 $23 - $62
4 Added 14.29%
32 $0
Q1 2022

May 16, 2022

BUY
$5.06 - $13.8 $45 - $124
9 Added 47.37%
28 $0
Q4 2021

Feb 14, 2022

BUY
$2.92 - $42.3 $2 - $42
1 Added 5.56%
19 $0
Q3 2021

Nov 15, 2021

SELL
$3.4 - $8.3 $3 - $8
-1 Reduced 5.26%
18 $0
Q2 2021

Aug 16, 2021

BUY
$5.2 - $8.13 $10 - $16
2 Added 11.76%
19 $0
Q1 2021

May 13, 2021

BUY
$5.66 - $8.45 $96 - $143
17 New
17 $0

Others Institutions Holding LGVN

About Longeveron Inc.


  • Ticker LGVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,925,940
  • Market Cap $12.2M
  • Description
  • Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is the LOMECEL-B, a cell-based therapy product that is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young healthy adult ...
More about LGVN
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.